Follow
SM Moghimi
SM Moghimi
Other namesS. Moein Moghimi, Seyed Moien Moghimi, Seyed M. Moghimi
Professor of Pharmaceutics and Nanomedicine; School of Pharmacy and Institute of Cellular Medicine
Verified email at ncl.ac.uk
Title
Cited by
Cited by
Year
Long-circulating and target-specific nanoparticles: theory to practice
SM Moghimi, AC Hunter, JC Murray
Pharmacological reviews 53 (2), 283-318, 2001
47772001
Nanomedicine: current status and future prospects
SM Moghimi, AC Hunter, JC Murray
The FASEB journal 19 (3), 311-330, 2005
27082005
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties
SM Moghimi, J Szebeni
Progress in lipid research 42 (6), 463-478, 2003
16132003
A two-stage poly (ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy
SM Moghimi, P Symonds, JC Murray, AC Hunter, G Debska, A Szewczyk
Molecular therapy 11 (6), 990-995, 2005
12662005
The possible “proton sponge” effect of polyethylenimine (PEI) does not include change in lysosomal pH
RV Benjaminsen, MA Mattebjerg, JR Henriksen, SM Moghimi, ...
Molecular Therapy 21 (1), 149-157, 2013
8152013
Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective
SM Moghimi, AC Hunter, TL Andresen
Annual review of pharmacology and toxicology 52, 481-503, 2012
6022012
Poloxamers and poloxamines in nanoparticle engineering and experimental medicine
SM Moghimi, AC Hunter
Trends in biotechnology 18 (10), 412-420, 2000
5192000
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo
F Chen, G Wang, JI Griffin, B Brenneman, NK Banda, VM Holers, ...
Nature nanotechnology 12 (4), 387-393, 2017
4982017
Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating
SM Moghimi, CJH Porter, IS Muir, L Illum, SS Davis
Biochemical and biophysical research communications 177 (2), 861-866, 1991
3601991
Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues
D Brambilla, B Le Droumaguet, J Nicolas, SH Hashemi, LP Wu, ...
Nanomedicine: Nanotechnology, Biology and Medicine 7 (5), 521-540, 2011
3572011
Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum
SM Moghimi, IS Muir, L Illum, SS Davis, V Kolb-Bachofen
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1179 (2), 157-165, 1993
3401993
Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system–the concept of tissue specificity
SM Moghimi, HM Patel
Advanced drug delivery reviews 32 (1-2), 45-60, 1998
3211998
Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions
TJ Anchordoquy, Y Barenholz, D Boraschi, M Chorny, P Decuzzi, ...
ACS nano 11 (1), 12-18, 2017
3202017
Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere− serum interface: implications for stealth nanoparticle engineering
I Hamad, O Al-Hanbali, AC Hunter, KJ Rutt, TL Andresen, SM Moghimi
ACS nano 4 (11), 6629-6638, 2010
3052010
Poly (ethylene glycol) s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process
I Hamad, AC Hunter, J Szebeni, SM Moghimi
Molecular immunology 46 (2), 225-232, 2008
2992008
Nanoparticles and innate immunity: new perspectives on host defence
D Boraschi, P Italiani, R Palomba, P Decuzzi, A Duschl, B Fadeel, ...
Seminars in immunology 34, 33-51, 2017
2942017
Material properties in complement activation
SM Moghimi, AJ Andersen, D Ahmadvand, PP Wibroe, TL Andresen, ...
Advanced drug delivery reviews 63 (12), 1000-1007, 2011
2822011
Dendrimers in medicine: therapeutic concepts and pharmaceutical challenges
L Wu, M Ficker, JB Christensen, PN Trohopoulos, SM Moghimi
Bioconjugate chemistry 26 (7), 1198-1211, 2015
2572015
Polycation cytotoxicity: a delicate matter for nucleic acid therapy—focus on polyethylenimine
L Parhamifar, AK Larsen, AC Hunter, TL Andresen, SM Moghimi
Soft Matter 6 (17), 4001-4009, 2010
2532010
Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response
S Mizrahy, SR Raz, M Hasgaard, H Liu, N Soffer-Tsur, K Cohen, R Dvash, ...
Journal of controlled release 156 (2), 231-238, 2011
2512011
The system can't perform the operation now. Try again later.
Articles 1–20